Genertec Universal Medical (2666) Announces Subsidiary’s Proposed Public Issuance of Fourth Tranche of Corporate Bonds in the PRC

Bulletin Express12-01

Genertec Universal Medical Group Company Limited (Stock Code: 2666) announced that its wholly-owned subsidiary, China Universal Leasing Co., Ltd. (the Issuer), plans to publicly issue the fourth tranche of corporate bonds (T4 Corporate Bonds) in the PRC. According to the announcement dated 1 December 2025, the Issuer’s corporate bond issuance was previously approved by the China Securities Regulatory Commission (CSRC) with a total principal amount of up to RMB8 billion. As of the issuance date, the outstanding principal of the corporate bonds stood at RMB5.4 billion.

The T4 Corporate Bonds, with a proposed principal amount not exceeding RMB1 billion, are expected to be issued off-line to qualified investors on the Shanghai Stock Exchange from 2 December 2025. These bonds will have a basic term of five years, featuring a repurchase option and a coupon rate adjustment option for the Issuer at the end of the third and fourth years. Investors will also have a sell-back option. The Issuer carries an AAA credit rating.

Relevant documents for the T4 Corporate Bonds will be published on the official website of the Shanghai Stock Exchange. The issuance of the Corporate Bonds is to be completed within 24 months from the date of the CSRC approval. The company will announce further progress on the remaining bonds as appropriate.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1137239073?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-01 16:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1137239073","market":"us","top_or_hot":-1,"title":"Genertec Universal Medical (2666) Announces Subsidiary’s Proposed Public Issuance of Fourth Tranche of Corporate Bonds in the PRC","media":"Bulletin Express","content":"<p>Genertec Universal Medical Group Company Limited (Stock Code: 2666) announced that its wholly-owned subsidiary, China Universal Leasing Co., Ltd. (the Issuer), plans to publicly issue the fourth tranche of corporate bonds (T4 Corporate Bonds) in the PRC. According to the announcement dated 1 December 2025, the Issuer’s corporate bond issuance was previously approved by the China Securities Regulatory Commission (CSRC) with a total principal amount of up to RMB8 billion. As of the issuance date, the outstanding principal of the corporate bonds stood at RMB5.4 billion.</p>\n<p>The T4 Corporate Bonds, with a proposed principal amount not exceeding RMB1 billion, are expected to be issued off-line to qualified investors on the Shanghai Stock Exchange from 2 December 2025. These bonds will have a basic term of five years, featuring a repurchase option and a coupon rate adjustment option for the Issuer at the end of the third and fourth years. Investors will also have a sell-back option. The Issuer carries an AAA credit rating.</p>\n<p>Relevant documents for the T4 Corporate Bonds will be published on the official website of the Shanghai Stock Exchange. The issuance of the Corporate Bonds is to be completed within 24 months from the date of the CSRC approval. The company will announce further progress on the remaining bonds as appropriate.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Genertec Universal Medical (2666) Announces Subsidiary’s Proposed Public Issuance of Fourth Tranche of Corporate Bonds in the PRC</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGenertec Universal Medical (2666) Announces Subsidiary’s Proposed Public Issuance of Fourth Tranche of Corporate Bonds in the PRC\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-12-01 16:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Genertec Universal Medical Group Company Limited (Stock Code: 2666) announced that its wholly-owned subsidiary, China Universal Leasing Co., Ltd. (the Issuer), plans to publicly issue the fourth tranche of corporate bonds (T4 Corporate Bonds) in the PRC. According to the announcement dated 1 December 2025, the Issuer’s corporate bond issuance was previously approved by the China Securities Regulatory Commission (CSRC) with a total principal amount of up to RMB8 billion. As of the issuance date, the outstanding principal of the corporate bonds stood at RMB5.4 billion.</p>\n<p>The T4 Corporate Bonds, with a proposed principal amount not exceeding RMB1 billion, are expected to be issued off-line to qualified investors on the Shanghai Stock Exchange from 2 December 2025. These bonds will have a basic term of five years, featuring a repurchase option and a coupon rate adjustment option for the Issuer at the end of the third and fourth years. Investors will also have a sell-back option. The Issuer carries an AAA credit rating.</p>\n<p>Relevant documents for the T4 Corporate Bonds will be published on the official website of the Shanghai Stock Exchange. The issuance of the Corporate Bonds is to be completed within 24 months from the date of the CSRC approval. The company will announce further progress on the remaining bonds as appropriate.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02666","symbol_name":"环球医疗","start_time":0,"source_url":"","article_id":"1137239073","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1137239073","pubTimestamp":1764578787,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Genertec Universal Medical Group Company Limited (Stock Code: 2666) announced that its wholly-owned subsidiary, China Universal Leasing Co., Ltd. (the Issuer), plans to publicly issue the fourth...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02666":"环球医疗"},"translate_title":"通用环球医疗(2666)公布附属公司拟于中国公开发行第四批公司债券","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02666":1},"content_text":"Genertec Universal Medical Group Company Limited (Stock Code: 2666) announced that its wholly-owned subsidiary, China Universal Leasing Co., Ltd. (the Issuer), plans to publicly issue the fourth tranche of corporate bonds (T4 Corporate Bonds) in the PRC. According to the announcement dated 1 December 2025, the Issuer’s corporate bond issuance was previously approved by the China Securities Regulatory Commission (CSRC) with a total principal amount of up to RMB8 billion. As of the issuance date, the outstanding principal of the corporate bonds stood at RMB5.4 billion.\nThe T4 Corporate Bonds, with a proposed principal amount not exceeding RMB1 billion, are expected to be issued off-line to qualified investors on the Shanghai Stock Exchange from 2 December 2025. These bonds will have a basic term of five years, featuring a repurchase option and a coupon rate adjustment option for the Issuer at the end of the third and fourth years. Investors will also have a sell-back option. The Issuer carries an AAA credit rating.\nRelevant documents for the T4 Corporate Bonds will be published on the official website of the Shanghai Stock Exchange. The issuance of the Corporate Bonds is to be completed within 24 months from the date of the CSRC approval. The company will announce further progress on the remaining bonds as appropriate.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1137239073","isCrawlerRequest":true}